Katsuaki Kanbe Selected Research

Katsuaki Kanbe Research Topics

Disease

25	Rheumatoid Arthritis 01/2020 - 01/2002
3	Infections 07/2014 - 02/2011
3	Osteoarthritis 09/2006 - 01/2002
2	Bursitis (Adhesive Capsulitis) 03/2018 - 01/2009
2	Necrosis 04/2009 - 09/2006
1	Synovitis 03/2018
1	Rheumatic Diseases (Rheumatism) 01/2016
1	Rotator Cuff Injuries 11/2013
1	Symptom Flare Up 05/2013
1	Bone Resorption 09/2012
1	Wounds and Injuries (Trauma) 02/2011
1	Hypertrophy 05/2010
1	Contracture 01/2009
1	Osteochondrodysplasias (Spondyloepiphyseal Dysplasia) 06/2008
1	Exanthema (Rash) 11/2006
1	Arthritis (Polyarthritis) 01/2002

Drug/Important Bio-Agent (IBA)

6	Infliximab (Remicade)FDA Link 01/2015 - 11/2006
5	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 06/2008
5	golimumab FDA Link 11/2017 - 01/2014
4	Mitogen-Activated Protein KinasesIBA 01/2016 - 09/2006
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2002
4	Interleukin-6 (Interleukin 6)IBA 01/2015 - 01/2009
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 11/2006
3	Abatacept (Orencia)FDA Link 01/2020 - 07/2013
3	C-Reactive ProteinIBA 01/2016 - 02/2011
3	Phosphotransferases (Kinase)IBA 01/2016 - 01/2009
3	tocilizumab (atlizumab)FDA Link 05/2013 - 11/2011
3	ChemokinesIBA 05/2010 - 01/2002
2	Capsules (Microcapsules)IBA 03/2018 - 01/2009
2	Etanercept (Enbrel)FDA Link 08/2011 - 04/2009
2	Matrix Metalloproteinases (MMPs)IBA 02/2011 - 01/2002
2	Chemokine CXCL12IBA 05/2010 - 01/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009 - 01/2009
2	Eosine Yellowish-(YS) (Eosin)IBA 04/2009 - 01/2009
2	Hematoxylin (Haematoxylon)IBA 04/2009 - 01/2009
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	MitogensIBA 01/2016
1	CXC ChemokinesIBA 01/2016
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2016
1	Prednisolone (Predate)FDA LinkGeneric 04/2015
1	InterleukinsIBA 01/2015
1	amsonic acid (DAS)IBA 11/2014
1	Chemokine ReceptorsIBA 07/2014
1	CytokinesIBA 01/2014
1	Polytetrafluoroethylene (Teflon)FDA Link 11/2013
1	OsteoprotegerinIBA 09/2012
1	Adalimumab (Humira)FDA Link 08/2011
1	Bromodeoxyuridine (BrdU)IBA 04/2009
1	NF-kappa B (NF-kB)IBA 01/2009
1	FibrinIBA 01/2009
1	Matrilin ProteinsIBA 06/2008
1	ChromatinIBA 09/2006
1	DNA (Deoxyribonucleic Acid)IBA 01/2006
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2002
1	ImmunosorbentsIBA 01/2002
1	Metalloproteases (Metalloproteinases)IBA 01/2002
1	EnzymesIBA 01/2002

Therapy/Procedure

6	Synovectomy 12/2017 - 11/2006
2	Orthopedic Procedures 01/2020 - 02/2011
2	Joint Capsule Release 03/2018 - 04/2015
2	Aftercare (After-Treatment) 01/2016 - 04/2008
2	Therapeutics 08/2011 - 06/2008
1	Conservative Treatment 03/2018
1	Intra-Articular Injections 01/2016
1	Subcutaneous Injections 01/2016
1	Perioperative Period 05/2013
1	Knee Replacement Arthroplasty (Total Knee Replacement) 04/2008